Related references
Note: Only part of the references are listed.Comparative effectiveness of omalizumab, mepolizumab, and dupilumab in asthma: A target trial emulation
Ayobami T. Akenroye et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2023)
Efficacy and safety of GSK3772847 in participants with moderate-to-severe asthma with allergic fungal airway disease: A phase IIa randomized, multicenter, double-blind, sponsor-open, comparative trial
Chika Akinseye et al.
PLOS ONE (2023)
Development of an inhaled anti-TSLP therapy for asthma
Paul M. O'Byrne et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2023)
Super-Responders to Biologic Treatment in Type 2–High Severe Asthma: Passing Fad or a Meaningful Phenotype?
Andrea Portacci et al.
Journal of Allergy and Clinical Immunology-In Practice (2023)
Treatable Traits in Airway Disease: From Theory to Practice
Alvar Agusti et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2023)
Toward a Predict and Prevent Approach in Obstructive Airway Diseases
Simon Couillard et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2023)
Questions in Mild Asthma An Official American Thoracic Society Research Statement
Arjun Mohan et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2023)
Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthma
Gail M. Gauvreau et al.
EUROPEAN RESPIRATORY JOURNAL (2023)
Investigational anti IL-13 asthma treatments: a 2023 update
Maria Gabriella Matera et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2023)
Severe Asthma and Biologics: Managing Complex Patients
A. Matucci et al.
JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY (2023)
Cardiovascular disease in asthma patients: From mechanisms to therapeutic implications
Mario Cazzola et al.
KARDIOLOGIA POLSKA (2023)
Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update
Mark L. Levy et al.
NPJ PRIMARY CARE RESPIRATORY MEDICINE (2023)
Anti-IL-33 monoclonal antibody Treatment of COPD and asthma Treatment of atopic dermatitis Treatment of diabetic kidney disease
Mario Cazzola et al.
DRUGS OF THE FUTURE (2023)
Endotyping Asthma: Profiling the Metabolic Dimension?
Michael J. Wilde et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)
Should we apply a treatable traits approach to asthma care?
Dr James Melhorn et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2022)
Global initiative for Asthma Strategy 2021: executive summary and rationale for key changes
Helen K. Reddel et al.
EUROPEAN RESPIRATORY JOURNAL (2022)
Tezepelumab administration in moderate-to-severe uncontrolled asthma: Is it all about eosinophils?
Pier Giorgio Puzzovio et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)
Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma
Celeste M. Porsbjerg et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2022)
Which Therapy for Non-Type(T)2/T2-Low Asthma
Fabio L. M. Ricciardolo et al.
JOURNAL OF PERSONALIZED MEDICINE (2022)
Single inhaler triple therapy (SITT) in asthma: Systematic review and practice implications
Alvar Agusti et al.
ALLERGY (2022)
T2-low: what do we know? Past, present, and future of biologic therapies in noneosinophilic asthma
Natalie M. Niessen et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2022)
Asthma remission: what is it and how can it be achieved?
Dennis Thomas et al.
EUROPEAN RESPIRATORY JOURNAL (2022)
An update on the currently available and emerging synthetic pharmacotherapy for uncontrolled asthma
Mario Cazzola et al.
EXPERT OPINION ON PHARMACOTHERAPY (2022)
Corticosteroid resistance in asthma: Cellular and molecular mechanisms
Gaetano Caramori et al.
MOLECULAR ASPECTS OF MEDICINE (2022)
Albuterol-Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma
Alberto Papi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 study
Michael E. Wechsler et al.
LANCET RESPIRATORY MEDICINE (2022)
Effectiveness of Interventions Targeting Treatable Traits for the Management of Obstructive Airway Diseases: A Systematic Review and Meta-Analysis
Muhammad Rehan Sarwar et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2022)
Potential Drawbacks of ICS/LABA/LAMA Triple Fixed-Dose Combination Therapy in the Treatment of Asthma: A Quantitative Synthesis of Safety Profile
Paola Rogliani et al.
JOURNAL OF ASTHMA AND ALLERGY (2022)
Phenotypes of Asthma-Chronic Obstructive Pulmonary Disease Overlap
Muhammad Adrish et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2022)
Unmet Needs and the Future of Asthma-Chronic Pulmonary Obstructive Disease Overlap
Mario Cazzola et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2022)
Pharmacologic Management Strategies of Asthma-Chronic Obstructive Pulmonary Disease Overlap
Nicola A. Hanania et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2022)
Clinical characteristics, treatment patterns and adherence in patients with asthma on multiple inhaler triple therapy: a review of findings
Mario Cazzola et al.
EXPERT REVIEW OF RESPIRATORY MEDICINE (2022)
Monoclonal antibodies in the management of asthma: Dead ends, current status and future perspectives
Grzegorz Kardas et al.
FRONTIERS IN IMMUNOLOGY (2022)
The 5T approach in asthma: Triple Therapy Targeting Treatable Traits
Mario Cazzola et al.
RESPIRATORY MEDICINE (2022)
Treatable traits in the NOVELTY study
Alvar Agusti et al.
RESPIROLOGY (2022)
Adherence and Persistence to Single-Inhaler Versus Multiple-Inhaler Triple Therapy for Asthma Management
Carlyne M. Averell et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2022)
Efficacy and Safety of Masitinib in Corticosteroid-Dependent Severe Asthma: A Randomized Placebo-Controlled Trial
Lavinia Davidescu et al.
JOURNAL OF ASTHMA AND ALLERGY (2022)
Pharmacological approaches to target type 2 cytokines in asthma
Laurent Guilleminault et al.
PHARMACOLOGY & THERAPEUTICS (2022)
Evolving Concept of Severe Asthma: Transition From Diagnosis to Treatable Traits
So -Young Park et al.
ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2022)
EAACI Biologicals Guidelines-Recommendations for severe asthma
Ioana Agache et al.
ALLERGY (2021)
Severe Adult Asthmas: Integrating Clinical Features, Biology, and Therapeutics to Improve Outcomes
Sally E. Wenzel
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)
National Asthma Education and Prevention Program 2020 Guideline Update: Where Do We Go from Here?
Jerry A. Krishnan et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)
Prospects for severe asthma treatment
Luigino Calzetta et al.
CURRENT OPINION IN PHARMACOLOGY (2021)
Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma
Michael E. Wechsler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Indacaterol, glycopyrronium, and mometasone: Pharmacological interaction and anti-inflammatory profile in hyperresponsive airways
Paola Rogliani et al.
PHARMACOLOGICAL RESEARCH (2021)
Treatable Mechanisms in Asthma
Mario Cazzola et al.
MOLECULAR DIAGNOSIS & THERAPY (2021)
SMART for the treatment of asthma: A network meta-analysis of real-world evidence
Paola Rogliani et al.
RESPIRATORY MEDICINE (2021)
Expert Consensus on the Tapering of Oral Corticosteroids for the Treatment of Asthma A Delphi Study
Carey M. Suehs et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)
Super-Responders to Severe Asthma Treatments: Defining a New Paradigm
Hitasha Rupani et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)
Triple vs Dual Inhaler Therapy and Asthma Outcomes in Moderate to Severe Asthma A Systematic Review and Meta-analysis
Lisa H. Y. Kim et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: A randomized clinical trial
Steven G. Kelsen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma
Andrew Menzies-Gow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Pulmonary Functional Imaging: Part 2-State-of-the-Art Clinical Applications and Opportunities for Improved Patient Care
Warren B. Gefter et al.
RADIOLOGY (2021)
Role of p38 Mitogen-Activated Protein Kinase in Asthma and COPD: Pathogenic Aspects and Potential Targeted Therapies
Corrado Pelaia et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2021)
Oral Corticosteroids Dependence and Biologic Drugs in Severe Asthma: Myths or Facts? A Systematic Review of Real-World Evidence
Luigino Calzetta et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Step-up and step-down approaches in the treatment of asthma
Mario Cazzola et al.
EXPERT REVIEW OF RESPIRATORY MEDICINE (2021)
Defining a Severe Asthma Super-Responder: Findings from a Delphi Process
John W. Upham et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)
Identification and treatment of T2-low asthma in the era of biologics
Chris Kyriakopoulos et al.
ERJ OPEN RESEARCH (2021)
The impact of the prostaglandin D2 receptor 2 and its downstream effects on the pathophysiology of asthma
Christopher E. Brightling et al.
ALLERGY (2020)
Factors that determine the loss of control when reducing therapy by steps in the treatment of moderate-severe asthma in standard clinical practice: A multicentre Spanish study
E. Martinez-Moragon et al.
REVISTA CLINICA ESPANOLA (2020)
The moderating role of allergy immunotherapy in asthma progression: Results of a population-based cohort study
Jochen Schmitt et al.
ALLERGY (2020)
Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline
Fernando Holguin et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Beclomethasone dipropionate, formoterol fumarate and glycopyrronium bromide: Synergy of triple combination therapy on human airway smooth muscle ex vivo
Paola Rogliani et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Rational oral corticosteroid use in adult severe asthma: A narrative review
Li Ping Chung et al.
RESPIROLOGY (2020)
Precision medicine and treatable traits in chronic airway diseases-where do we stand?
Charlotte Suppli Ulrik et al.
CURRENT OPINION IN PULMONARY MEDICINE (2020)
TSLP Inhibitors for Asthma: Current Status and Future Prospects
Maria Gabriella Matera et al.
DRUGS (2020)
Targeting treatable traits in severe asthma: a randomised controlled trial
Vanessa M. McDonald et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
An expert consensus framework for asthma remission as a treatment goal
Andrew Menzies-Gow et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Pharmacology and Therapeutics of Bronchodilators Revisited
M. G. Matera et al.
PHARMACOLOGICAL REVIEWS (2020)
SMART and as-needed therapies in mild-to-severe asthma: a network meta-analysis
Paola Rogliani et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
T2-Low Asthma: Overview and Management Strategies
Anne M. Fitzpatrick et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2020)
New perspectives on the role of muscarinic antagonists in asthma therapy
Maria Gabriella Matera et al.
EXPERT REVIEW OF RESPIRATORY MEDICINE (2020)
The latest on the role of LAMAs in asthma
Mario Cazzola et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
A Critical Role for the CXCL3/CXCL5/CXCR2 Neutrophilic Chemotactic Axis in the Regulation of Type 2 Responses in a Model of Rhinoviral-Induced Asthma Exacerbation
Leon A. Sokulsky et al.
JOURNAL OF IMMUNOLOGY (2020)
2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group
Michelle M. Cloutier et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Severe Asthma and Biological Therapy: When, Which, and for Whom
Paola Rogliani et al.
PULMONARY THERAPY (2020)
Asthma and COPD overlap: a treatable trait or common several treatable-traits?
J. Gaspar Marques et al.
EUROPEAN ANNALS OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Omalizumab Effectiveness by Biomarker Status in Patients with Asthma: Evidence From PROSPERO, A Prospective Real-World Study
Thomas B. Casale et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)
Treatable traits: a new paradigm for 21st century management of chronic airway diseases: Treatable Traits Down Under International Workshop report
Vanessa M. McDonald et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Precision medicine and phenotypes, endotypes, genotypes, regiotypes, and theratypes of allergic diseases
Ioana Agache et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Controlled Trial of Budesonide-Formoterol as Needed for Mild Asthma
Richard Beasley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Unmet therapeutic goals and potential treatable traits in a population of patients with severe uncontrolled asthma in Spain. ENEAS study
Luis Perez de Llano et al.
RESPIRATORY MEDICINE (2019)
Bronchodilators in subjects with asthma-related comorbidities
Mario Cazzola et al.
RESPIRATORY MEDICINE (2019)
Evolving Concepts in Chronic Obstructive Pulmonary Disease Blood-Based Biomarkers
Mario Cazzola et al.
MOLECULAR DIAGNOSIS & THERAPY (2019)
Normalisation of MRI ventilation heterogeneity in severe asthma by dupilumab
Sarah Svenningsen et al.
THORAX (2019)
IL-33 Mediated Inflammation in Chronic Respiratory Diseases-Understanding the Role of the Member of IL-1 Superfamily
Agata Gabryelska et al.
FRONTIERS IN IMMUNOLOGY (2019)
Hot Topic: Precision Medicine for Asthma-Has the Time Come?
Xingnan Li
CURRENT ALLERGY AND ASTHMA REPORTS (2019)
The efficacy and safety of long-term add-on treatment of azithromycin in asthma A systematic review and meta-analysis
Xiaohu Wang et al.
MEDICINE (2019)
Acute effects of salbutamol on systemic vascular function in people with asthma
Linn E. Moore et al.
RESPIRATORY MEDICINE (2019)
Inhaled Corticosteroid Therapy in Adult Asthma Time for a New Therapeutic Dose Terminology
Richard Beasley et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
The many faces of asthma-chronic obstructive pulmonary disease overlap
Louis-Philippe Boulet et al.
CURRENT OPINION IN PULMONARY MEDICINE (2019)
The Intriguing Role of Interleukin 13 in the Pathophysiology of Asthma
Giancarlo Marone et al.
FRONTIERS IN PHARMACOLOGY (2019)
Targeting cell signaling in allergic asthma
Seyyed Shamsadin Athari
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2019)
Severe Asthma in Primary Care: Identification and Management
Jennifer L. Trevor et al.
AMERICAN JOURNAL OF MEDICINE (2018)
Pharmacological mechanisms leading to synergy in fixed-dose dual bronchodilator therapy
Luigino Calzetta et al.
CURRENT OPINION IN PHARMACOLOGY (2018)
After asthma: redefining airways diseases
Ian D. Pavord et al.
LANCET (2018)
Inhaled Combined Budesonide-Formoterol as Needed in Mild Asthma
Paul M. O'Byrne et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Tralokinumab for severe, uncontrolled asthma (STRATOS 1 and STRATOS 2): two randomised, double-blind, placebo-controlled, phase 3 clinical trials
Reynold A. Panettieri et al.
LANCET RESPIRATORY MEDICINE (2018)
IL-4 and IL-13 Receptor Signaling From 4PS to Insulin Receptor Substrate 2: There and Back Again, a Historical View
Achsah D. Keegan et al.
FRONTIERS IN IMMUNOLOGY (2018)
Anti-IgE or Anti-IL5: That Is the Question
Elliot Israel et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2018)
Risk Factors for Asthma Exacerbation and Treatment Failure in Adults and Adolescents with Well-controlled Asthma during Continuation and Step-Down Therapy
Emily DiMango et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2018)
Beclomethasone dipropionate and formoterol fumarate synergistically interact in hyperresponsive medium bronchi and small airways
Luigino Calzetta et al.
RESPIRATORY RESEARCH (2018)
Ensifentrine (RPL554): an inhaled bifunctional' dual PDE3/4 inhibitor for the treatment of asthma and chronic obstructive pulmonary disease
Mario Cazzola et al.
PHARMACEUTICAL PATENT ANALYST (2018)
Inhalation therapy in the next decade: Determinants of adherence to treatment in asthma and COPD
Claudio F. Donner et al.
MONALDI ARCHIVES FOR CHEST DISEASE (2018)
Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study
Akbar K. Waljee et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Why and how to step down chronic asthma drugs
Michael R. Gionfriddo et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study
Akbar K. Waljee et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Why and how to step down chronic asthma drugs
Michael R. Gionfriddo et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Role of muscarinic antagonists in asthma therapy
Mario Cazzola et al.
EXPERT REVIEW OF RESPIRATORY MEDICINE (2017)
Personalised medicine in asthma: from curative to preventive medicine
Laurent Guilleminault et al.
EUROPEAN RESPIRATORY REVIEW (2017)
Addition of anti-leukotriene agents to inhaled corticosteroids for adults and adolescents with persistent asthma (Review)
Bhupendrasinh F. Chauhan et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)
Precision medicine in patients with allergic diseases: Airway diseases and atopic dermatitis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology
Antonella Muraro et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Interaction between corticosteroids and muscarinic antagonists in human airways
Mario Cazzola et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2016)
Can bronchial asthma with an highly prevalent airway (and systemic) vagal tone be considered an independent asthma phenotype? Possible role of anticholinergics
Gennaro Liccardi et al.
RESPIRATORY MEDICINE (2016)
A 12-year prognosis of adult-onset asthma: Seinajoki Adult Asthma Study
Leena E. Tuomisto et al.
RESPIRATORY MEDICINE (2016)
Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials
Nicola A. Hanania et al.
LANCET RESPIRATORY MEDICINE (2016)
Anti-inflammatory potential of PI3Kδ and JAK inhibitors in asthma patients
Thomas Southworth et al.
RESPIRATORY RESEARCH (2016)
Evolving Concepts of Asthma
Marc Gauthier et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Strategies targeting the IL-4/IL-13 axes in disease
Richard D. May et al.
CYTOKINE (2015)
Seventy Years of Asthma in Italy: Age, Period and Cohort Effects on Incidence and Remission of Self-Reported Asthma from 1940 to 2010
Giancarlo Pesce et al.
PLOS ONE (2015)
Type 2 inflammation in asthma - present in most, absent in many
John V. Fahy
NATURE REVIEWS IMMUNOLOGY (2015)
Defining Phenotypes in Asthma: A Step Towards Personalized Medicine
Kian Fan Chung
DRUGS (2014)
Bifunctional drugs for the treatment of asthma and chronic obstructive pulmonary disease
Clive Page et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Outcomes of childhood asthma to the age of 50 years
Andrew Tai et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Exploring the Effects of Omalizumab in Allergic Asthma An Analysis of Biomarkers in the EXTRA Study
Nicola A. Hanania et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Differential Roles of CXCL2 and CXCL3 and Their Receptors in Regulating Normal and Asthmatic Airway Smooth Muscle Cell Migration
Laila A. Al-Alwan et al.
JOURNAL OF IMMUNOLOGY (2013)
Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial
Guy G. Brusselle et al.
THORAX (2013)
The potential use of tyrosine kinase inhibitors in severe asthma
Vamsi P. Guntur et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Asthma phenotypes: the evolution from clinical to molecular approaches
Sally E. Wenzel
NATURE MEDICINE (2012)
Tremor and β2-adrenergic agents: Is it a real clinical problem?
Mario Cazzola et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2012)
Effect of Bronchoconstriction on Airway Remodeling in Asthma
Christopher L. Grainge et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma
Xiaojin Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma
Thomas E. Delea et al.
CLINICAL THERAPEUTICS (2008)
Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: a comparison
I. S. T. Bos et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Use of oral corticosteroids and the risk of acute myocardial infarction
Cristina Varas-Lorenzo et al.
ATHEROSCLEROSIS (2007)
Corticosteroids and the risk of atrial fibrillation
Cornelis S. van der Hooft et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Inhibition of Rho-kinase normalizes nonspecific hyperresponsiveness in passively sensitized airway smooth muscle preparations
D Schaafsma et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease
L Wei et al.
ANNALS OF INTERNAL MEDICINE (2004)
A longitudinal, population-based, cohort study of childhood asthma followed to adulthood
MR Sears et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Kinetic analysis of the interleukin-13 receptor complex
AL Andrews et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma
DA Kuperman et al.
NATURE MEDICINE (2002)